A new meta-analysis published in The Lancet Healthy Longevity — “The impact of exercise interventions on domains of quality of life in women diagnosed with breast cancers during chemotherapy treatment”
Exercise works — even during chemotherapy.
For women undergoing chemotherapy for breast cancer, treatment can be physically and emotionally exhausting. Fatigue, pain, brain fog, mood changes, and loss of physical strength are common. Historically, many patients were told to “rest” and conserve energy. But modern exercise oncology research continues to challenge that outdated advice.
This study analyzed 21 randomized controlled trials involving more than 3,000 women receiving active chemotherapy. The results were compelling: women who exercised during treatment reported significantly better quality of life than those receiving standard care alone.
What Did the Study Find?
The overall improvement in quality of life was moderate and clinically meaningful. In practical terms, women who exercised had about a two-thirds likelihood of feeling better overall compared with women who did not exercise.
Importantly, benefits were seen across several key areas:
- Global quality of life
- Physical health
- Mental health
- Fatigue and symptom burden
Mental health improvements were particularly notable. Exercise helped reduce distress, improve mood, and support emotional resilience during treatment.
What Type of Exercise Works?
The encouraging news: multiple types of exercise were effective.
- Aerobic exercise (walking, cycling, treadmill work)
- Combined aerobic + strength training
- Strength training alone
All showed meaningful benefits.
No single modality was clearly superior. That means exercise can be individualized based on:
- Energy level
- Treatment cycle timing
- Access to supervision
- Personal preference
- Joint health or cardiotoxicity concerns
In other words, the best exercise program is the one a patient can safely and consistently do.
Why Does Exercise Help During Chemotherapy?
Exercise isn’t just about fitness — it’s biological medicine.
The study highlights several mechanisms:
- Reduced systemic inflammation
- Improved stress hormone regulation
- Enhanced endorphin release
- Better cardiometabolic stability
- Preservation of muscle mass and function
These mechanisms directly counteract common chemotherapy side effects like fatigue, mood disturbance, and physical decline.
What This Means for Patients
If you are undergoing chemotherapy for breast cancer:
- You are not fragile.
- Movement is not dangerous when appropriately guided.
- Exercise can help you feel better during treatment — not just after.
Even modest, structured activity can improve how you feel physically and emotionally.
Always discuss plans with your oncology team, especially if you have neutropenia, cardiotoxicity concerns, or other complications. But in most cases, appropriately prescribed exercise is safe and beneficial.
What This Means for Oncology Providers
This meta-analysis strengthens existing ASCO recommendations to encourage aerobic and resistance exercise during active treatment.
Exercise should no longer be viewed as optional or peripheral. It is a core supportive care strategy.
Oncology practices should consider:
- Embedding exercise referrals into care pathways
- Partnering with exercise oncology professionals
- Providing home-based protocols when supervised programs are not feasible
- Educating patients early — at diagnosis
The CancerFitness.org Perspective
At CancerFitness.org, we believe exercise is a form of treatment — not merely lifestyle advice.
This study reinforces a fundamental principle:
During chemotherapy, exercise improves quality of life.
The goal is not athletic performance. The goal is to preserve agency, strength, emotional stability, and resilience during one of the most challenging phases of cancer care.
Movement is medicine.
And during chemotherapy, it matters.
Reference: The impact of exercise interventions on domains of quality of life in women diagnosed with breast cancers during chemotherapy treatment: a meta-analytic review.
LaShae D Rolle, Soyeon Ahn, Elle M Mezzio, Madalyn Wheeler, Loren Yavelberg, Carmen J Calfa, Sophia H L George, Kathryn H Schmitz, Tracy E Crane. Published Online: https://doi.org/10.1016/j.lanhl.2026.100819